Novartis India Limited
NSE: NOVARTIND | Information Technology
Market Fundamentals
Stock Intelligence & News
Who Is Vas Narasimhan? Novartis CEO Appointed To Anthropic's Board
Vas Narasimhan, CEO, Novartis
Read Full Analysis →Novartis CEO Vas Narasimhan Joins Anthropic Board Ahead Of Potential IPO
The board expansion comes amid reports that Anthropic is evaluating a potential initial public offering that could materialise as early as this year.
Read Full Analysis →Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Anthropic adds Novartis CEO Vas Narasimhan to its board
Anthropic adds Novartis CEO Vas Narasimhan to its board
Read Full Analysis →Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Read Full Analysis →Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Read Full Analysis →Novartis to buy experimental breast cancer drug in up to $3 billion deal
Novartis to buy experimental breast cancer drug in up to $3 billion deal
Read Full Analysis →Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Read Full Analysis →Avidity (RNA) Moves Date for Shareholder Vote on Novartis Merger
Avidity (RNA) Moves Date for Shareholder Vote on Novartis Merger
Read Full Analysis →Novartis completes acquisition of Avidity Biosciences; shares to be delisted from Nasdaq
Novartis completes acquisition of Avidity Biosciences; shares to be delisted from Nasdaq
Read Full Analysis →Get instant alerts when NOVARTIND breaks news
Join investors who track Novartis India Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for NOVARTIND?
NOVARTIND is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Novartis India Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding NOVARTIND to your custom watchlist.